Dr. Chilbert is a clinical assistant professor who teaches and practices in cardiology. Her practice site is at Buffalo General Medical Center in the cardiac intensive care unit. Her teaching is primarily focused in the pathophysiology and pharmacotherapeutics of cardiology disease states.
Education and Training:
Certificate, Board Certified Cardiology Specialist, Board of Pharmacy Specialties (2019)
Residency, Cardiology Pharmacy Practice, The Ohio State University Wexner Medical Center (2019)
Residency, Pharmacy Practice, The Ohio State University Wexner Medical Center (2018)
PharmD, University at Buffalo School of Pharmacy and Pharmaceutical Sciences (2017)
Employment:
Cardiology Pharmacy Practice Resident, The Ohio State University Wexner Medical Center (2018–2019)
Pharmacy Practice Resident, The Ohio State University Wexner Medical Center (2017–2018)
Awards and Honors:
Excellence in Teaching Award (2023)
Department of Pharmacy Practice Teaching Award (2022)
Western New York Residency Preceptor of the Year (2022)
Chapter Alumni of the Year (2021)
Educator of the Year (2021)
Research Award (First Runner-Up), American College of Cardiology (2019)
Best Student Poster Award, American College of Clinical Pharmacy (2017)
Leadership Award, Phi Delta Chi (2017)
Student Award, Western New York Society of Health-System Pharmacists (2017)
Resident Travel Award, American College of Clinical Pharmacy (2017)
Award for Academic Excellence (2017)
Phi Lambda Sigma, Beta Omicron Chapter (2016)
William C. Dambach Scholarship (2016)
Walmart Scholar, American Association of Colleges of Pharmacy (2016)
Dr. Willis Gregory Scholarship (2015)
Excellence in Pharmaceutical Sciences Award (2015)
Rho Chi National Honors Society Inductee (2014)
Research Expertise:
Cardiology
Professional Memberships:
American Academy of Colleges of Pharmacy (AACP) (2022–present)
New York State American College of Clinical Pharmacy (2019–present)
American College of Cardiology (ACC); member (2018–present)
American College of Clinical Pharmacy (ACCP) (2016–present)
American Society of Health System Pharmacists (2015–present)
New York State Society of Health Systems Pharmacists (2015–present)
Presentations:
"Remodeling the Heart Failure Approach: An Update to the Heart Failure with Reduced Ejection Fraction Treatment Guidance." WNYSCHP Continuing Education Series; WNYSCHP; Cardiology (2021)
"A Fluid shift: Integrating SGLT-2 Inhibitors into standard heart failure care" NYSCHP Internal Medicine and Cardiology Webinar Series; NYSCHP; Cardiology (2021)
"Comparison of bleeding rates between oral anticoagulants used in combination with dual antiplatelet therapy (triple therapy) in a real-world cohort" ACCP Annual Meeting; ACCP; Poster Session (2020)
"Evaluation of Intensified Low Molecular Weight Heparin or Unfractionated Heparin for Venous Thromboembolism Prophylaxis in Critically Ill Patients with COVID-19" ACCP Annual Meeting; ACCP; Poster Session (2020)
"Four-Factor Prothrombin Complex Concentrate for Reversal of Apixaban and Rivaroxaban" ACCP Annual Meeting; ACCP; Poster Session (2019)
"Clinical outcomes following treatment of Enterobacter pneumonia with piperacillin/tazobactam compared to cefepime or ertapenem" Great Lakes Pharmacy Residency Conference; Great Lake Pharmacy (2018)
"Increased risk of acute kidney injury in critically ill children treated with vanocmycin and piperacillin/tazobactam" American College of Clinical Pharmacy Annual Meeting; American College of Clinical Pharmacy (2017)
"Retrospective review of 30-day readmission rates in pulmonary embolism patients treated with a direct-acting oral anticoagulant with and without follow-up" American College of Cardiology Annual Meeting; American College of Cardiology (2017)
"The utility of procalcitonin to support clinical decision making in critically ill pediatric patients" American College of Clinical Pharmacy Annual Meeting; American College of Clinical Pharmacy (2016)